About Repligen India Private Limited
Data last updated: 12 March 2026
Repligen India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of M/S Spectrum Europe. It specialises in medical equipment retail and distribution, a part of the broader healthcare sector. Incorporated on 03 March 2016, the company has been in operation for over 10 years.
Registered with ROC Bangalore under CIN U29300KA2016FTC086606.
Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. Formerly known as Spectrumlabs India Private Limited. It is led by directors Vijay David Williams Sugumar and Narasimha Murthy Sathyanarayana.
Last AGM: 07 August 2025. Financial statements filed for year ended 31 March 2025. Office: Third Floor Indiqube Courtyard Marriot 2/55 Veranna Palya Hebbal, Bangalore, Karnataka, India – 560045.
As per the financials filed for FY 2025, the company reported a revenue of ₹110.29 Cr, a growth of 48% compared to the previous year.
The company has a workforce of approximately 21 employees as per the latest available data. It operates as a subsidiary of M/S Spectrum Europe.
The company is associated with 1 brand - Repligen. As per MCA filings, the company has open charges of ₹34.02 Lakh and satisfied charges of ₹34.02 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website repligen.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressThird Floor Indiqube Courtyard Marriot 2/55 Veranna Palya Hebbal, Bangalore, Karnataka, India – 560045
-
IndustryHealthcare, Medical Equipment Retail & Distribution
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Repligen India Private Limited
Repligen India Private Limited operates one associated brand: Repligen. These brands represent Repligen India Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Products and services for biologic drug manufacturing are supplied. | repligen.com |
Competitors & Alternatives of Repligen India Private Limited
Brands and companies operating in the same space as Repligen India Private Limited include Sutro Biopharma, Synthego, Avidity Biosciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | United States | 2003 |
|
|
CRISPR-engineered cell and gene therapies are developed for research applications. | Redwood City, United States, United States | 2012 |
|
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
|
|
Yeast cells are genetically engineered to produce medicinal products. | Palo Alto, United States, United States | 2013 |
|
|
Developing novel drugs based on a proteome-wide ligand and target discovery platform | Oceanside, United States, United States | 2016 |
|
|
RNA-editing technologies are provided for precision medicine applications. | Cambridge, United States, United States | 2018 |
|
|
Developer of novel drugs from fungi via genome mining and recombinant overexpression | Cambridge, United States, United States | 2016 |
|
|
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | Austin, United States, United States | 2008 |
|
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | Charleroi, Belgium, Belgium | 2013 |
|
|
Developer of pharmaceuticals and vaccines for various therapeutic areas | Brentford, United Kingdom, United Kingdom | - |
Business Activity of Repligen India Private Limited
Repligen India Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details for Repligen India Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Repligen India Private Limited
Repligen India Private Limited is audited by K.P. Rao & Co for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.P. Rao & Co | Locked | Locked | Locked |
Complete auditor history for Repligen India Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Repligen India Private Limited
Repligen India Private Limited is currently managed by 2 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay David Williams Sugumar | Director | 22 Jun 2022 | 4 Years 1 Months | Current |
| Narasimha Murthy Sathyanarayana | Director | 22 Jul 2024 | 2 Years 0 Months | Current |
Financials of Repligen India Private Limited FY 2025 filings available
Repligen India Private Limited reported revenue of ₹110.29 Cr (up 48.00% YoY) for FY 2025.
Ten-year financial statements for Repligen India Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Repligen India Private Limited
Shareholding and ownership data for Repligen India Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Repligen India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Hdfc Bank Limited | ₹34.02 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Repligen India Private Limited
Repligen India Private Limited has a workforce of 21 employees as of Mar 30, 2024.
Employee and EPFO history for Repligen India Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Repligen India Private Limited
GST registrations and filing compliance for Repligen India Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Repligen India Private Limited
Credit ratings, litigation, and regulatory alerts for Repligen India Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Repligen India Private Limited
MSME payment history for Repligen India Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Repligen India Private Limited
Corporate group structure for Repligen India Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Repligen India Private Limited
MCA filings and documents for Repligen India Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Repligen India Private Limited
Frequently Asked Questions about Repligen India Private Limited
Repligen India Private Limited is an active foreign private limited company in the healthcare sector based in Bangalore, Karnataka, India. It was incorporated on 03 March 2016 (10+ years old) and is registered under CIN U29300KA2016FTC086606. The company has 21 employees.
Repligen India Private Limited reported revenue of ₹110.29 Cr for FY 2025 (up 48.00% YoY).
The current directors of Repligen India Private Limited are:
- Vijay David Williams Sugumar - Director
- Narasimha Murthy Sathyanarayana - Director
The primary industry of Repligen India Private Limited is healthcare. The company specifically operates in medical equipment retail and distribution. The company is currently active in this sector.
Repligen India Private Limited can be reached at the registered office: Third Floor Indiqube Courtyard Marriot 255 Veranna Palya Hebbal, Bangalore, Karnataka, India – 560045, or through the website repligen.com.
The authorised capital is ₹2 Cr, and the paid-up capital is ₹2 Cr.